ANTENGENE-B (06996): Hou Bing appointed as Chief Scientific Officer.
Deqi Pharmaceuticals-B (06996) issued an announcement, and the company's board of directors is pleased to announce the appointment of Dr. Hou Bing as Chief Scientific Officer, reporting directly to Dr. Mei Jianming, founder, chairman, and CEO of Deqi Pharmaceuticals.
ANTENGENE-B (06996) announced that the Board of Directors is pleased to appoint Dr. Hou Bing as Chief Scientific Officer, reporting directly to Dr. Mei Jianming, founder, Chairman, and CEO of Deqi Pharmaceuticals.
Related Articles
ITC PROPERTIES (00199) strategic upgrade, reconstructing long-term growth foundation with AI computing power.
GMTEight List of A-share restricted sales and lifting restrictions | May 20th
RSUN SER (01971) will be suspended from trading starting from May 20th to wait for the publication of insider information.
ITC PROPERTIES (00199) strategic upgrade, reconstructing long-term growth foundation with AI computing power.
GMTEight List of A-share restricted sales and lifting restrictions | May 20th
RSUN SER (01971) will be suspended from trading starting from May 20th to wait for the publication of insider information.
